Most Read Articles
Roshini Claire Anthony, 19 Sep 2017

The addition of the glucagon-like peptide-1 analogue semaglutide to standard of care resulted in sustained reduction in weight and waist circumference in individuals with type 2 diabetes (T2D) with high cardiovascular risk, according to the phase III SUSTAIN 6* trial presented at EASD 2017.

21 Dec 2017
Vitamin C supplementation appears to yield significant reductions in glucose concentrations in patients with diabetes, particularly older individuals and those with more prolonged supplementation, according to a study.
26 Dec 2017
Supplementation with omega-3 fatty acids in combination with rosuvastatin may yield significant reductions in triglycerides and nonhigh-density lipoprotein (HDL) cholesterol as compared with rosuvastatin monotherapy, according to data from the ROMANTIC (rosuvastatin-omacor in residual hypertriglyceridemia) trial.
01 Dec 2014

Q: Introduction to perimenopause – when it begins, what are the signs and symptoms?
A: Many women do not realize that menopause does not happen over 24 hours. For a period of 10 to 15 years before menopause is established at the average age of 51, a woman will already be undergoing a period of change in a phase of life known as perimenopause or ‘around menopause’. Perimenopause is typically experienced by women aged between 40 and 56.

Change in abdominal visceral fat predicts future pulse pressure

6 days ago

The accumulation of abdominal visceral fat over time is an independent predictor of future arterial pulse pressure, which is a marker of arterial stiffness, according to a recent study involving Japanese Americans.

A positive association existed between 10-year pulse pressure and change in abdominal visceral fat area at 5 years independent of sex, 5-year change in body mass index (BMI), and baseline age, BMI, pulse pressure, abdominal visceral fat, smoking status, alcohol consumption, physical activity, homeostasis model assessment insulin resistance and fasting plasma glucose.

No significant associations were observed between baseline amounts or change in abdominal or thigh subcutaneous fat areas and future pulse pressure.

Computed tomography was used to measure visceral fat as well as abdominal and thigh subcutaneous fat areas at baseline and 5 years later in Japanese Americans (n=284; mean age 49.3 years; 50.4 percent men) without hypertension, heart disease and glucose-lowering medication use at baseline.

Pulse pressure at 10 years was calculated as the difference between systolic and diastolic blood pressure with a mercury sphygmomanometer. Using linear regression analysis, the investigators examined the correlation between change in fat at 5 years and arterial pulse pressure at 10 years, adjusted for baseline pulse pressure.

In an earlier study, Hayashi and colleagues found that greater visceral adiposity increased the risk for hypertension in Japanese Americans. Intraabdominal fat area significantly predicted hypertension even after adjustment for total subcutaneous fat area, abdominal subcutaneous fat area or waist circumference. [Ann Intern Med 2004;140:992-1000]

Both body composition and pulse pressure are risk factors for cardiovascular disease, according to the investigators.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 19 Sep 2017

The addition of the glucagon-like peptide-1 analogue semaglutide to standard of care resulted in sustained reduction in weight and waist circumference in individuals with type 2 diabetes (T2D) with high cardiovascular risk, according to the phase III SUSTAIN 6* trial presented at EASD 2017.

21 Dec 2017
Vitamin C supplementation appears to yield significant reductions in glucose concentrations in patients with diabetes, particularly older individuals and those with more prolonged supplementation, according to a study.
26 Dec 2017
Supplementation with omega-3 fatty acids in combination with rosuvastatin may yield significant reductions in triglycerides and nonhigh-density lipoprotein (HDL) cholesterol as compared with rosuvastatin monotherapy, according to data from the ROMANTIC (rosuvastatin-omacor in residual hypertriglyceridemia) trial.
01 Dec 2014

Q: Introduction to perimenopause – when it begins, what are the signs and symptoms?
A: Many women do not realize that menopause does not happen over 24 hours. For a period of 10 to 15 years before menopause is established at the average age of 51, a woman will already be undergoing a period of change in a phase of life known as perimenopause or ‘around menopause’. Perimenopause is typically experienced by women aged between 40 and 56.